We are a Swiss company focusing on the value development and commercialization of promising early-stage research projects from universities and other research institutions in the life sciences industry with the goal to offer solutions for high unmet medical need and better life quality. Our goal is to build a bridge from research and development to the healthcare markets.
We bring selected projects in the four areas of technology platforms, biotechnologies/therapies, medical technology (health technology), and artificial intelligence in the life science sector and digital health to the next stage of development.
Xlife Sciences and its project companies act in a responsible and sustainable way. We are able to reduce animal testing to a minimum through innovative technologies. In addition, we regularly engage in innovative healing trials for severe and partly incurable diseases. This has a great impact for treated patients. Sustainability has also high priority in the production. In the area of bioprinting and pharmaceuticals, project companies produce with low energy consumption and little by-products. We support sustainable business travel and are a sustainability sponsor of Carbon Connect.
Please fill out this form in order to receive media releases from Xlife Sciences